Thank you for requesting Keys to Successfully Entering the US Market - Business Development and Licensing Journal .
To download a copy of this document, please provide the following basic information:When launching a product in the US market for the first time, ex-US companies have three options: build the commercial organization out on their own, partner with a big pharmaceutical company, or buy a smaller US-based company with the right resources already in place to do the job. Each of the three main strategic options for bringing a product into the US market carries its own set of advantages and disadvantages. Deciding which strategy to pursue is a complicated undertaking. In the September issue of the European Pharma Licensing Group’s Business Development & Licensing Journal, we detail some of the complexities of the US market, the broad range of considerations executives will need to make as they weigh the commercial opportunities for their product in the US, and strategies to use in choosing a US marketing partner.